Clorazepate dipotassium

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

A certified analytical reference solution suitable for use in benzodiazepine testing methods by GC/MS or LC/MS for applications in clinical toxicology, urine drug testing or forensic analysis. Clorazepate dipotassium is a long-acting benzodiazepine

This stable-labeled internal standard is suitable for quantification of clorazepate by LC/MS or GC/MS for clinical toxicology, forensic analysis, or urine drug testing applications. Clorazepate dipotassium is a long-acting benzodiazepine with

Application Human dipeptidyl peptidase III has been used in a study to assess the effect of entropy-driven binding of opioid peptides on large domain motion in human dipeptidyl peptidase III. Human dipeptidyl peptidase III has also been used in a

Dipeptidyl Peptidase IV (DPP4) is mapped to human chromosome 2q24.2.

C-terminal histidine-tagged. Soluble form (residues 29-766) MW 105 kDa Application Human dipeptidyl peptidase IV has been used to study interactive hemodynamic effects of its inhibition and angiotensin-converting enzyme inhibition in humans.

Application Human dipeptidyl peptidase VIII has been used in a study to identify ERGIC-53 as an intracellular transport receptor of &#9451-antitrypsin. Human dipeptidyl peptidase VIII has also been used in a study to investigate the cargo

Other Notes Please note that Sigma-Aldrich provides this product to early discovery researchers as part of a collection of rare and unique chemicals. Sigma-Aldrich does not collect analytical data for this product.

Oleoyl Coenzyme A Dipotassium Salt